Skip to content
Inciteful Med

Managing Your Risk: Standard Treatments and Care

Last updated:

Treatment for Brugada syndrome is highly personalized based on your risk of sudden cardiac arrest. High-risk patients typically receive an Implantable Cardioverter-Defibrillator (ICD), while others may benefit from medication like quinidine, catheter ablation, or strict lifestyle modifications.

Key Takeaways

  • • An Implantable Cardioverter-Defibrillator (ICD) is the gold standard treatment for Brugada syndrome patients at high risk of sudden cardiac arrest.
  • • The medication quinidine helps stabilize the heart's electrical system and prevents dangerous arrhythmias.
  • • Epicardial catheter ablation is an advanced procedure that neutralizes the abnormal heart tissue causing irregular rhythms.
  • • All patients with Brugada syndrome must aggressively manage fevers and avoid specific prohibited medications.

Treating Brugada syndrome (BrS) is not “one size fits all.” Because the condition ranges from a very low-risk electrical pattern to a high risk of cardiac arrest, your treatment plan will be tailored to your specific risk level and clinical history [1][2].

The Gold Standard: Implantable Cardioverter-Defibrillator (ICD)

For patients at high risk, the Implantable Cardioverter-Defibrillator (ICD) remains the most widely accepted and effective strategy for preventing sudden cardiac death [3][4]. An ICD is a small, battery-powered device placed under the skin that monitors your heart rhythm 24/7. If it detects a dangerous, fast rhythm (like ventricular fibrillation), it delivers an electrical shock to “reset” the heart [5].

  • Who needs one? Current guidelines strongly recommend an ICD for patients who have already survived a cardiac arrest (secondary prevention) or those who have a spontaneous Type 1 ECG and have experienced fainting (syncope) presumed to be of cardiac origin [1][2].
  • Asymptomatic Patients: If you have never had symptoms, the decision is much more complex. Doctors may use an Electrophysiology Study (EPS)—a procedure where they try to “induce” an arrhythmia in a controlled setting—to help decide if an ICD is necessary [6][7].

Medical Management: Quinidine

While device therapy is the standard for high-risk patients, pharmacologic therapy plays a crucial role for many. Quinidine is a medication that can help stabilize the heart’s electricity [8][3].

  • How it works: It acts as a sodium channel blocker but crucially, it also inhibits the transient outward potassium current (Ito\text{I}_{\text{to}}). By shifting this balance of currents during early repolarization, it helps prevent the dangerous Brugada arrhythmias [8][9].
  • When it’s used: Quinidine is often used as an adjunct or alternative to an ICD, especially for patients who experience frequent “shocks” from their device (electrical storms), or those who refuse or cannot have an ICD implanted [3][9].

Advanced Treatment: Catheter Ablation

For patients experiencing recurrent ventricular fibrillation or those suffering from multiple ICD shocks, a procedure called epicardial catheter ablation has emerged as a crucial intervention [10][11].

  • The Target: Doctors have identified that the proarrhythmic substrate—the abnormal tissue causing the “glitch”—is primarily located on the outer surface (epicardium) of the Right Ventricular Outflow Tract (RVOT) [9][12].
  • The Procedure: Using a thin tube (catheter), an electrophysiologist applies radiofrequency energy to modify or “neutralize” these specific abnormal electrograms [13][12].
  • The Goal: Catheter ablation has shown durable efficacy in suppressing recurrent ventricular fibrillation, potentially reducing the need for aggressive medication or enduring repeated, painful ICD shocks [14][15].

Ongoing Management

Whether you receive an ICD, take quinidine, or undergo ablation, your treatment does not stop there. The cornerstone of care for every Brugada patient, regardless of their medical interventions, is strict lifestyle modification—specifically aggressive fever management and avoiding prohibited drugs [3][16].

Frequently Asked Questions

Who needs an ICD for Brugada syndrome?
An Implantable Cardioverter-Defibrillator (ICD) is strongly recommended for high-risk patients, especially those who have survived a cardiac arrest or experienced fainting linked to an abnormal heart rhythm.
How does quinidine help treat Brugada syndrome?
Quinidine is a medication that helps stabilize the heart's electrical system by blocking specific sodium and potassium channels. It is often used to prevent dangerous arrhythmias, particularly in patients who experience frequent shocks from their ICD.
What is epicardial catheter ablation for Brugada syndrome?
Epicardial catheter ablation is a procedure where a doctor uses a thin tube to deliver radiofrequency energy to the outside of the heart. This neutralizes the abnormal tissue causing the rhythm issues, helping to prevent recurrent irregular heartbeats and reduce ICD shocks.
Can Brugada syndrome be managed without an ICD?
For asymptomatic patients with a very low risk, doctors may sometimes recommend a careful observation approach. This involves aggressive fever reduction and strictly avoiding certain medications that can trigger an arrhythmia.
What lifestyle changes are required if I have Brugada syndrome?
The cornerstone of care for all patients with Brugada syndrome is aggressive fever management, as high body temperatures can trigger arrhythmias. Patients must also strictly avoid specific prohibited drugs that can interfere with the heart's electrical system.

Questions for Your Doctor

  • • Am I considered high-risk, and what is my estimated annual risk of a cardiac event?
  • • Would you recommend a transvenous ICD or a subcutaneous ICD (S-ICD) for my specific situation?
  • • If I choose quinidine, what side effects should I watch for, and how often will I need blood tests or ECGs?
  • • Is epicardial catheter ablation an option for me, and how many of these procedures has this facility performed for Brugada syndrome?
  • • If I am currently asymptomatic, can we use an 'observation only' approach with aggressive fever management instead of an ICD?

Questions for You

  • • How do I feel about the prospect of living with an implanted device (ICD) versus taking a daily medication with potential side effects?
  • • Have I had any fainting spells or 'seizure-like' episodes that could actually be undiagnosed heart rhythm issues?
  • • Am I comfortable with the lifestyle changes required for an ICD, such as avoiding certain magnetic fields or high-impact sports?

Want personalized information?

Type your question below to get evidence-based answers tailored to your situation.

References

  1. 1

    Brugada type 1 electrocardiogram: Should we treat the electrocardiogram or the patient?

    Delise P, Allocca G, Sitta N

    World journal of cardiology 2017; (9(9)):737-741 doi:10.4330/wjc.v9.i9.737.

    PMID: 29081906
  2. 2

    Brugada Syndrome: Fatal Consequences of a Must-Not-Miss Diagnosis.

    Smith LD, Gast S, Guy DF

    Critical care nurse 2021; (41(5)):15-22 doi:10.4037/ccn2021499.

    PMID: 34595496
  3. 3

    Brugada Syndrome.

    Krahn AD, Behr ER, Hamilton R, et al.

    JACC. Clinical electrophysiology 2022; (8(3)):386-405 doi:10.1016/j.jacep.2021.12.001.

    PMID: 35331438
  4. 4

    Risk Stratification in Brugada Syndrome: Current Status and Emerging Approaches.

    Honarbakhsh S, Providencia R, Lambiase PD

    Arrhythmia & electrophysiology review 2018; (7(2)):79-83 doi:10.15420/aer.2018.2.2.

    PMID: 29967678
  5. 5

    [Acute chest pain revealing a Brugada syndrome].

    Daniella RM, Anjaramalala R, Ramiandrisoa , et al.

    The Pan African medical journal 2016; (25()):95 doi:10.11604/pamj.2016.25.95.9442.

    PMID: 28292058
  6. 6

    Performance of electrophysiologic study in an asymptomatic patient with type 2 intermittent Brugada syndrome: To do or not to do.

    Hosseini K, Jahangiri M, Vasheghani Farahani A

    Caspian journal of internal medicine 2018; (9(1)):92-95 doi:10.22088/cjim.9.1.92.

    PMID: 29387326
  7. 7

    Genetics of Brugada syndrome.

    Juang JJ, Horie M

    Journal of arrhythmia 2016; (32(5)):418-425 doi:10.1016/j.joa.2016.07.012.

    PMID: 27761167
  8. 8

    Brugada Syndrome: Clinical, Genetic, Molecular, Cellular, and Ionic Aspects.

    Antzelevitch C, Patocskai B

    Current problems in cardiology 2016; (41(1)):7-57.

    PMID: 26671757
  9. 9

    Ablation for the treatment of Brugada syndrome: current status and future prospects.

    Rizzo A, de Asmundis C, Brugada P, et al.

    Expert review of medical devices 2020; (17(2)):123-130 doi:10.1080/17434440.2020.1719831.

    PMID: 31986921
  10. 10

    Brugada syndrome: a review and the role of epicardial ablation in management.

    Abuzuagaia OJ, Abozguia K, Darrat Y

    The Egyptian heart journal : (EHJ) : official bulletin of the Egyptian Society of Cardiology 2024; (76(1)):55 doi:10.1186/s43044-024-00485-3.

    PMID: 38713300
  11. 11

    Epicardial radiofrequency catheter ablation of Brugada syndrome with electrical storm during ventricular fibrillation: A case report.

    Jiang S, Yin X, Dong C, et al.

    Medicine 2017; (96(46)):e8688 doi:10.1097/MD.0000000000008688.

    PMID: 29145303
  12. 12

    Contemporary Perspectives on J-Wave Syndromes: An Expert Consensus Statement.

    Nademanee K, Wilde AA, Ackerman MJ, et al.

    Journal of arrhythmia 2026; (42(1)):e70284 doi:10.1002/joa3.70284.

    PMID: 41738055
  13. 13

    Epicardial Ablation for Arrhythmogenic Disorders in Patients with Brugada Syndrome.

    Matteucci A, Mariani MV, Sgarra L, et al.

    Biomedicines 2024; (13(1)) doi:10.3390/biomedicines13010027.

    PMID: 39857610
  14. 14

    Long-Term Outcomes of Brugada Substrate Ablation: A Report from BRAVO (Brugada Ablation of VF Substrate Ongoing Multicenter Registry).

    Nademanee K, Chung FP, Sacher F, et al.

    Circulation 2023; (147(21)):1568-1578 doi:10.1161/CIRCULATIONAHA.122.063367.

    PMID: 36960730
  15. 15

    Combined Right Ventricular Outflow Tract Epicardial and Endocardial Late Potential Ablation for Treatment of Brugada Storm: A Case Report and Review of the Literature.

    Saha SA, Krishnan K, Madias C, Trohman RG

    Cardiology and therapy 2016; (5(2)):229-243 doi:10.1007/s40119-016-0072-4.

    PMID: 27646458
  16. 16

    More than 30 years of Brugada syndrome: a critical appraisal of achievements and open issues.

    Eckardt L, Veltmann C

    Herzschrittmachertherapie & Elektrophysiologie 2024; (35(1)):9-18 doi:10.1007/s00399-023-00983-y.

    PMID: 38085327

This information about Brugada syndrome treatments is for educational purposes only. Always consult your cardiologist or electrophysiologist to determine the safest treatment plan for your specific risk level.

Stay up to date

Get notified when new research about Brugada syndrome is published.

No spam. Unsubscribe anytime.